MENU
SUPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Supernus Pharmaceuticals (SUPN) Ownership - Who owns Supernus Pharmaceuticals?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
9715 Key West Avenue
Phone
+1 301 838-2500
Employees
652
Web
https://www.supernus.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
1.84B
P/E Ratio
1677.00
Total Cash
254.87M
Projected Growth
N/A
Total Debt
41.53M
Revenue
607.52M
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash/Share
4.66
Total Debt/Equity
97.74
Revenue/Share
10.95 USD as % of share price
Fundamentals
SUPN
Capitalization
1.84B
P/E Ratio
1677.00
Risk (Beta)
0.74
Dividend Yield
N/A
Total Cash
255M
Total Cash/Share
4.66
Total Debt
41.5M
Total Debt/Equity
97.74
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
10.95%
Revenue
608M
ROE
N/A
Book Value
922M
P/B Ratio
1.99
Cash Flow
N/A
Earnings
0.02
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
55K
Current Ratio
1.70
Current Revenue Per Employee
252015.34
Dividends Per Share - Security
N/A
EBITDA
90M
Float
N/A
Float - Current
N/A
Gross Income Margin
88.06
Revenue To Assets
0.09
Shares Held By Institutions
4.47B
Shares Outstanding - Current
54.7M
Total Liabilities
356M
Total Volume MTD
N/A
Value
-1
Gain YTD
19.938
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer for the treatment of central nervous system
Industry PharmaceuticalsOther
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
9715 Key West Avenue
Phone
+1 301 838-2500
Employees
652
Web
https://www.supernus.com